Previous 10 | Next 10 |
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB, and a global leader in the development, manufacture and commercialization of innovative diagnostic an...
Lantheus Holdings, Inc. (LNTH) Q3 2020 Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer Conference Cal...
Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q3 2020 Earnings Call Nov 5, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q3 2020 Earnings Call Transcript
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Lantheus Holdings, Inc. 2020 Q3 - Results - Earnings Call Presentation
Lantheus (LNTH): Q3 Non-GAAP EPS of $0.04 beats by $0.10; GAAP EPS of -$0.10 beats by $0.07.Revenue of $88.54M (+3.2% Y/Y) misses by $3.42M.Press Release For further details see: Lantheus EPS beats by $0.10, misses on revenue
Worldwide revenue of $88.5 million for the third quarter 2020, representing an increase of 3.2% from the prior year period Net loss of $6.4 million for the third quarter 2020, compared to net income of $4.9 million in the prior year period GAAP diluted EPS of $(0.10)...
Lantheus (NASDAQ:LNTH) is scheduled to announce Q3 earnings results on Thursday, November 5th, before market open.The consensus EPS Estimate is -$0.06 (-121.4% Y/Y) and the consensus Revenue Estimate is $91.96M (+7.2% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time ...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB, and a global leader in the development, manufacture and commercialization of innovative diagnostic and th...
Lantheus Holdings (LNTH) will collaborate with privately held Haifa, Israel-based Insightec Ltd. to evaluate the use of LNTH's microbubbles, combined with Insightec's investigational MR-guided Focused Ultrasound (MRgFUS) platform, for the treatment of glioblastoma and neurodegenerative condit...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced a str...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...